Literature DB >> 25731584

Morphometric and histological parameters in veins of diabetic patients undergoing brachiocephalic fistula placement.

Ivana Lazich1, Anthony Chang2, Sydeaka Watson3, Promila Dhar4, Rama S Madhurapantula5, Mary Hammes1.   

Abstract

Diabetic patients with end-stage renal failure have higher rates of arteriovenous failures when compared with nondiabetics. The aim was to compare differences in indicators of vascular remodeling and endothelial dysfunction in veins of patients with or without diabetes at the time of surgical placement. In this prospective observational trial, vein samples were collected from patients when a brachiocephalic fistula was created. Morphometric measurements and extent of fibrosis were determined using Image J software. Histological analysis, for the presence of myofibroblasts and level of endothelial nitric oxide synthase, was performed by immunohistochemical staining and scored in semi-quantitative manner. Asymmetric dimethylarginine was determined at the time of access placement. Comparison of diabetics and nondiabetics was performed using Wilcoxon rank sum and Fisher's exact tests. Eighteen patients were included; 10 were diabetics. There was a significant difference in the measurement of vein area between groups, with diabetic vein samples having larger luminal area of average 832,001.18 μm(2) (317,582.17-3,695,670.36, P = 0.04). The maximal intimal to medial thickness ratio was higher in diabetic vein samples (0.71 vs. 0.24, P = 0.03) along with statistically significant higher maximal intimal thickness (312.12 vs. 115.14 μm, P = 0.03). There is a significant difference in vascular wall remodeling between diabetics and nondiabetics at the level of the cephalic vein at the time of brachiocephalic placement. The unexpected finding of significantly larger luminal area in diabetic veins could be a major factor positively affecting brachiocephalic outcomes in otherwise impaired remodeling in this patient population.
© 2015 International Society for Hemodialysis.

Entities:  

Keywords:  Fistula; diabetes; intimal hyperplasia; vascular disease

Mesh:

Year:  2015        PMID: 25731584      PMCID: PMC4558389          DOI: 10.1111/hdi.12289

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  32 in total

Review 1.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

Authors:  Mark A Creager; Thomas F Lüscher; Francesco Cosentino; Joshua A Beckman
Journal:  Circulation       Date:  2003-09-23       Impact factor: 29.690

2.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

3.  Linking endothelial dysfunction with endothelial cell activation.

Authors:  James K Liao
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

4.  Natural history of venous morphologic changes in dialysis access stenosis.

Authors:  Timmy Lee; Maheshika Somarathna; Arjan Hura; Yang Wang; Begona Campos; Lois Arend; Rino Munda; Prabir Roy-Chaudhury
Journal:  J Vasc Access       Date:  2014-02-04       Impact factor: 2.283

Review 5.  Arteriovenous access failure: more than just intimal hyperplasia?

Authors:  Tonia C Rothuizen; Chunyu Wong; Paul H A Quax; Anton Jan van Zonneveld; Ton J Rabelink; Joris I Rotmans
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

6.  Primary vascular access in diabetic patients: an audit.

Authors:  K Konner
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

7.  Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes.

Authors:  M Sedlacek; V Teodorescu; A Falk; J A Vassalotti; J Uribarri
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

8.  Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.

Authors:  K M Ceballos; G P Nielsen; M K Selig; J X O'Connell
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

9.  Impact of arterial microcalcification of the vascular access on cardiovascular mortality in hemodialysis patients.

Authors:  Yu Seon Yun; Su Jin Choi; Ja Young Lee; Young Soo Kim; Sun Ae Yoon; Sun Chul Park; Ok Ran Shin; Eun Joung Jang; Young Ok Kim
Journal:  Hemodial Int       Date:  2013-08-06       Impact factor: 1.812

10.  2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.

Authors:  Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04       Impact factor: 8.311

View more
  5 in total

Review 1.  Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences.

Authors:  Roberto I Vazquez-Padron; Juan C Duque; Marwan Tabbara; Loay H Salman; Laisel Martinez
Journal:  Kidney360       Date:  2021-08

2.  Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Authors:  Charles E Alpers; Peter B Imrey; Kelly L Hudkins; Tomasz A Wietecha; Milena Radeva; Michael Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Yan-Ting Shiu; Christi M Terry; Alik Farber; Gerald J Beck; Harold I Feldman; John W Kusek; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2017-07-19       Impact factor: 10.121

Review 3.  Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients.

Authors:  Mary Hammes
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

4.  Role of a RhoA/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage.

Authors:  Gonzalo I Gómez; Victoria Velarde; Juan C Sáez
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

5.  Asymmetric Dimethylarginine does not Predict Early Access Events in Hemodialysis Patients with Brachiocephalic Fistula Access.

Authors:  Mary Hammes; Rita McGill; Promila Dhar; Rama S Madhurapantula
Journal:  Int J Nephrol Kidney Fail       Date:  2017-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.